(Boston University) Researchers at Boston University School of Medicine have, for the first time, found that angiotensin receptor blockers -- a particular class of anti-hypertensive medicines -- are associated with a striking decrease in the occurrence and progression of dementia.
Data from this study will be presented this weekend at the 2008 International Conference on Alzheimer's disease in Chicago.